Understanding how antibodies affect hepatitis E virus infection
Role of antibodies in hepatitis E virus infection
This study is looking at how antibodies can help fight hepatitis E, especially for people with weakened immune systems, to see if they can prevent or treat long-lasting infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-11061061 on NIH RePORTER |
What this research studies
This research investigates the role of antibodies in hepatitis E virus (HEV) infection, particularly focusing on how these antibodies can potentially prevent or treat chronic HEV infections. The study examines two forms of the virus and how they interact with the immune system, especially in patients with compromised immunity. By analyzing the effectiveness of antibodies generated from natural infections and vaccinations, the research aims to uncover mechanisms that could lead to improved treatments for chronic hepatitis E. Patients may be involved in trials that assess the impact of antibody levels on disease progression and treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with chronic hepatitis E infection, particularly those with weakened immune systems.
Not a fit: Patients with acute hepatitis E infections that resolve without treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively prevent or cure chronic hepatitis E infections, improving liver health for affected patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of antibodies in viral infections, suggesting that this approach could yield significant insights into hepatitis E treatment.
Where this research is happening
Columbus, United States
- Research Inst Nationwide Children's Hosp — Columbus, United States (Active)
Researchers
- Principal investigator: Feng, Zongdi — Research Inst Nationwide Children's Hosp
- Study coordinator: Feng, Zongdi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.